TESTOSTERONE REPLACEMENT THERAPY IN MEN WITH TYPE 2 DIABETES MELLITUS: A LITERATURE REVIEW
DOI:
https://doi.org/10.47820/recima21.v6i7.6610Keywords:
Anabolic Androgenic Steroids; Diabetes Mellitus; Therapy.Abstract
Type 2 Diabetes Mellitus (T2DM) is associated with hormonal dysfunctions, such as reduced free and bioavailable testosterone, especially in men. Testosterone replacement therapy (TRT) has emerged as a complementary strategy to improve glycemic control, body composition, and cardiovascular parameters in hypogonadal diabetic patients. This article reviews the main mechanisms and clinical evidence supporting the use of anabolic androgenic steroids as an adjuvant therapy in T2DM, highlighting benefits in insulin sensitivity, inflammatory profile, and muscle strength.
Downloads
References
DHINDSA, Sandeep et al. Insulin resistance and inflammation in hypogonadotropic hypogonadism and their reduction after testosterone replacement in men with type 2 diabetes. Diabetes care, v. 39, n. 1, p. 82-91, 2016. DOI: https://doi.org/10.2337/dc15-1518
DING, Bo et al. Men with Latent Autoimmune Diabetes and Type 2 Diabetes May Have Different Change Patterns in Free Testosterone. BioMed Research International, v. 2020, n. 1, p. 6259437, 2020. DOI: https://doi.org/10.1155/2020/6259437
GROTI ANTONIČ, Kristina. Impact of testosterone therapy on bone turnover markers in obese males with type 2 diabetes and functional hypogonadism. The Aging Male, v. 25, n. 1, p. 269-277, 2022. DOI: https://doi.org/10.1080/13685538.2022.2134338
GROTI, Kristina et al. The impact of testosterone replacement therapy on glycemic control, vascular function, and components of the metabolic syndrome in obese hypogonadal men with type 2 diabetes. The Aging Male, v. 21, n. 3, p. 158-169, 2018. DOI: https://doi.org/10.1080/13685538.2018.1468429
KHRIPUN, Irina et al. Influence of testosterone substitution on glycemic control and endothelial markers in men with newly diagnosed functional hypogonadism and type 2 diabetes mellitus: a randomized controlled trial. The Aging Male, 2019. DOI: https://doi.org/10.1080/13685538.2018.1506918
KOVAC, Jason R. et al. A positive role for anabolic androgenic steroids: preventing metabolic syndrome and type 2 diabetes mellitus. Fertility and Sterility, v. 102, n. 1, p. e5, 2014. DOI: https://doi.org/10.1016/j.fertnstert.2014.05.010
MAGNUSSEN, Line V. et al. Effect of testosterone on insulin sensitivity, oxidative metabolism and body composition in aging men with type 2 diabetes on metformin monotherapy. Diabetes, Obesity and Metabolism, v. 18, n. 10, p. 980-989, 2016. DOI: https://doi.org/10.1111/dom.12701
MAGNUSSEN, Line Velling et al. Testosterone therapy preserves muscle strength and power in aging men with type 2 diabetes—a randomized controlled trial. Andrology, v. 5, n. 5, p. 946-953, 2017. DOI: https://doi.org/10.1111/andr.12396
MAGNUSSEN, Line Velling. Testosterone therapy of men with type 2 diabetes mellitus: a randomized, double-blinded, placebo-controlled study. Danish Medical Journal, v. 64, n. 7, p. B5396, 2017.
ROBLEDO, Kristy P. et al. Mediation analysis of the testosterone treatment effect to prevent type 2 diabetes in the Testosterone for Prevention of Type 2 Diabetes Mellitus trial. European Journal of Endocrinology, v. 189, n. 1, p. 50-57, 2023. DOI: https://doi.org/10.1093/ejendo/lvad074
ROBLEDO, Kristy P. et al. Predicting type 2 diabetes and testosterone effects in high-risk Australian men: development and external validation of a 2-year risk model. European Journal of Endocrinology, v. 192, n. 1, p. 15-24, 2025. DOI: https://doi.org/10.1093/ejendo/lvae166
ZHANG, Jianzhong et al. Association between testosterone with type 2 diabetes in adult males, a meta-analysis and trial sequential analysis. The Aging Male, 2020. DOI: https://doi.org/10.1080/13685538.2018.1557139
ZHANG, K.-S. et al. Effects of testosterone supplementation therapy on lipid metabolism in hypogonadal men with T2DM: a meta‐analysis of randomized controlled trials. Andrology, v. 6, n. 1, p. 37-46, 2018. DOI: https://doi.org/10.1111/andr.12425
Downloads
Published
License
Copyright (c) 2025 RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218
This work is licensed under a Creative Commons Attribution 4.0 International License.
Os direitos autorais dos artigos/resenhas/TCCs publicados pertecem à revista RECIMA21, e seguem o padrão Creative Commons (CC BY 4.0), permitindo a cópia ou reprodução, desde que cite a fonte e respeite os direitos dos autores e contenham menção aos mesmos nos créditos. Toda e qualquer obra publicada na revista, seu conteúdo é de responsabilidade dos autores, cabendo a RECIMA21 apenas ser o veículo de divulgação, seguindo os padrões nacionais e internacionais de publicação.
